Balaji Veeraraghavan
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria 185
-
- Antibiotic Use and Resistance 45
- Endocrinology top 0.1%
- Vibrio bacteria research studies 65
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 53
- Infectious Diseases top 1%
- Antimicrobial Resistance in Staphylococcus 38
-
- Pneumonia and Respiratory Infections 59
-
- Salmonella and Campylobacter epidemiology 57
-
- Antibiotics Pharmacokinetics and Efficacy 51
- Co-authors
- Shalini AnandanNaveen Kumar Devanga RagupathiAgila Kumari PragasamYamuna Devi BakthavatchalamChaitra ShankarDhiviya Prabaa Muthuirulandi SethuvelKāmini WaliaIndranil Biswas
- Journals
- Nucleic Acids Research (1 paper)Nature Communications (2 papers)SHILAP Revista de lepidopterología (3 papers)
- Partner nations
- IndiaUnited StatesUnited Kingdom
In The Last Decade
Balaji Veeraraghavan
371 papers receiving 6.5k citations
Peers
Comparison fields: 5 of 166
- Molecular Medicine 3.2k
- Applied Microbiology and Biotechnology 945
- Endocrinology 1.6k
- Clinical Biochemistry 783
- Infectious Diseases 1.3k
Countries citing papers authored by Balaji Veeraraghavan
This map shows the geographic impact of Balaji Veeraraghavan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Balaji Veeraraghavan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Balaji Veeraraghavan more than expected).
Fields of papers citing papers by Balaji Veeraraghavan
This network shows the impact of papers produced by Balaji Veeraraghavan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Balaji Veeraraghavan. The network helps show where Balaji Veeraraghavan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Balaji Veeraraghavan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 16 | |
| 8 | 2024 | 5 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 0 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 11 | |
| 14 | 2021 | 0 | |
| 15 | 2021 | 3 | |
| 16 | 2020 | 4 | |
| 17 | 2019 | 27 | |
| 18 | 2016 | 10 | |
| 19 | 2013 | 27 | |
| 20 | 2012 | 33 |
About Balaji Veeraraghavan
Balaji Veeraraghavan is a scholar working on Molecular Medicine, Endocrinology and Applied Microbiology and Biotechnology, having authored 388 papers that have together received 6.6k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (185 papers), Vibrio bacteria research studies (65 papers), Pneumonia and Respiratory Infections (59 papers), Salmonella and Campylobacter epidemiology (57 papers), Bacterial Identification and Susceptibility Testing (53 papers), Antibiotics Pharmacokinetics and Efficacy (51 papers), Antibiotic Use and Resistance (45 papers) and Antimicrobial Resistance in Staphylococcus (38 papers). The work is most often cited by research in Molecular Medicine (3.2k citations), Applied Microbiology and Biotechnology (945 citations) and Endocrinology (1.6k citations). Balaji Veeraraghavan has collaborated with scholars based in India, United States and United Kingdom. Frequent co-authors include Shalini Anandan, Naveen Kumar Devanga Ragupathi, Agila Kumari Pragasam, Yamuna Devi Bakthavatchalam, Chaitra Shankar, Dhiviya Prabaa Muthuirulandi Sethuvel, Kāmini Walia, Indranil Biswas, Saranya Vijayakumar and Laura Nabarro. Their work appears in journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.